The epigenetic regulation of podocyte function in diabetes

Journal of Diabetes and its Complications

Volumn 29, Issue 8, 2015, Pages 1337-1344

  Majumder, Syamantak ^a   Advani, Andrew ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Acetylation; Epigenetic; Histone; Methylation; Podocyte

Indexed keywords

ACTIVATED PROTEIN C; CLAUDIN 1; GELATINASE B; GLUCOSE; HISTONE DEACETYLASE; HISTONE DEACETYLASE 4; HISTONE METHYLTRANSFERASE; KRUPPEL LIKE FACTOR 4; LYSINE; MANGANESE SUPEROXIDE DISMUTASE; MICRORNA 125B; NICOTINAMIDE; NICOTINAMIDE NUCLEOTIDE; SIRTUIN 1; HISTONE;

ALBUMINURIA; ARTICLE; AUTOPHAGY; CELL DIFFERENTIATION; CELL FUNCTION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CLINICAL TRIAL (TOPIC); DEACETYLATION; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DNA METHYLATION; EPIGENETICS; EVIDENCE BASED PRACTICE; EXPERIMENTAL STUDY; GENE EXPRESSION; GENETIC REGULATION; GLOMERULUS; GLYCEMIC CONTROL; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; KIDNEY DISEASE; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; OXIDATIVE STRESS; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); VASCULAR SMOOTH MUSCLE CELL; ACETYLATION; ANIMAL; BIOLOGICAL MODEL; COMPLICATION; EVIDENCE BASED MEDICINE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PROTEIN PROCESSING;

ACETYLATION; ANIMALS; AUTOPHAGY; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DNA METHYLATION; EPIGENESIS, GENETIC; EVIDENCE-BASED MEDICINE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HISTONES; HUMANS; MODELS, BIOLOGICAL; OXIDATIVE STRESS; PODOCYTES; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84948710135     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2015.07.015     Document Type: Review

References (72)

1. A. Advani, Q. Huang, K. Thai, S.L. Advani, K.E. White, D.J. Kelly, and et al. Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism The American Journal of Pathology 178 2011 2205 2214
2. C.G. Bell, A.E. Teschendorff, V.K. Rakyan, A.P. Maxwell, S. Beck, and D.A. Savage Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus BMC Medical Genomics 3 2010 33
3. F. Bock, K. Shahzad, H. Wang, S. Stoyanov, J. Wolter, W. Dong, and et al. Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc Proceedings of the National Academy of Sciences of the United States of America 110 2013 648 653
4. D. Brasacchio, J. Okabe, C. Tikellis, A. Balcerczyk, P. George, E.K. Baker, and et al. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail Diabetes 58 2009 1229 1236
5. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820
6. L.H. Chen, S.L. Advani, K. Thai, M.G. Kabir, M.M. Sood, I.W. Gibson, and et al. SDF-1/CXCR4 signaling preserves microvascular integrity and renal function in chronic kidney disease PloS One 9 2014 e92227
7. I.H. de Boer Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study Diabetes Care 37 2014 24 30
8. I.H. de Boer, W. Sun, P.A. Cleary, J.M. Lachin, M.E. Molitch, M.W. Steffes, and et al. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes New England Journal of Medicine 365 2011 2366 2376
9. S. Doublier, G. Salvidio, E. Lupia, V. Ruotsalainen, D. Verzola, G. Deferrari, and et al. Nephrin expression is reduced in human diabetic nephropathy: Evidence for a distinct role for glycated albumin and angiotensin II Diabetes 52 2003 1023 1030
10. G.R. Dressler, and S.R. Patel Epigenetics in kidney development and renal disease Translational Research 165 2015 166 176
11. A. El-Osta, D. Brasacchio, D. Yao, A. Pocai, P.L. Jones, R.G. Roeder, and et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia Journal of Experimental Medicine 205 2008 2409 2417
12. R.L. Engerman, and T.S. Kern Progression of incipient diabetic retinopathy during good glycemic control Diabetes 36 1987 808 812
13. C. Gao, G. Chen, L. Liu, X. Li, J. He, L. Jiang, and et al. Impact of high glucose and proteasome inhibitor MG132 on histone H2A and H2B ubiquitination in rat glomerular mesangial cells Journal of Diabetes Research 2013 2013 589474
14. H.C. Gerstein, M.E. Miller, R.P. Byington, D.C. Goff Jr., J.T. Bigger, J.B. Buse, and et al. Effects of intensive glucose lowering in type 2 diabetes New England Journal of Medicine 358 2008 2545 2559
15. R.E. Gilbert, Q. Huang, K. Thai, S.L. Advani, K. Lee, D.A. Yuen, and et al. Histone deacetylase inhibition attenuates diabetes-associated kidney growth: Potential role for epigenetic modification of the epidermal growth factor receptor Kidney International 79 2011 1312 1321
16. K. Hasegawa, S. Wakino, P. Simic, Y. Sakamaki, H. Minakuchi, K. Fujimura, and et al. Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes Nature Medicine 19 2013 1496 1504
17. K. Hayashi, H. Sasamura, M. Nakamura, T. Azegami, H. Oguchi, Y. Sakamaki, and et al. KLF4-dependent epigenetic remodeling modulates podocyte phenotypes and attenuates proteinuria The Journal of Clinical Investigation 124 2014 2523 2537
18. W. He, Y. Wang, M.Z. Zhang, L. You, L.S. Davis, H. Fan, and et al. Sirt1 activation protects the mouse renal medulla from oxidative injury The Journal of Clinical Investigation 120 2010 1056 1068
19. R.R. Holman, S.K. Paul, M.A. Bethel, D.R. Matthews, and H.A. Neil 10-year follow-up of intensive glucose control in type 2 diabetes New England Journal of Medicine 359 2008 1577 1589
20. J. Hou, and D. Zhao MicroRNA regulation in renal pathophysiology International Journal of Molecular Sciences 14 2013 13078 13092
21. K.T. Howitz, K.J. Bitterman, H.Y. Cohen, D.W. Lamming, S. Lavu, J.G. Wood, and et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Nature 425 2003 191 196
22. B. Isermann, I.A. Vinnikov, T. Madhusudhan, S. Herzog, M. Kashif, J. Blautzik, and et al. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis Nature Medicine 13 2007 1349 1358
23. M. Kato, J.T. Park, and R. Natarajan MicroRNAs and the glomerulus Experimental Cell Research 318 2012 993 1000
24. S.T. Keating, and A. El-Osta Chromatin modifications associated with diabetes Journal of Cardiovascular Translational Research 5 2012 399 412
25. M. Kitada, S. Kume, N. Imaizumi, and D. Koya Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway Diabetes 60 2011 634 643
26. Y.A. Ko, D. Mohtat, M. Suzuki, A.S. Park, M.C. Izquierdo, S.Y. Han, and et al. Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development Genome Biology 14 2013 R108
27. S. Kume, T. Uzu, K. Horiike, M. Chin-Kanasaki, K. Isshiki, S. Araki, and et al. Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney The Journal of Clinical Investigation 120 2010 1043 1055
28. G.M. Lefevre, S.R. Patel, D. Kim, L. Tessarollo, and G.R. Dressler Altering a histone H3K4 methylation pathway in glomerular podocytes promotes a chronic disease phenotype PLoS Genetics 6 2010 e1001142
29. U. Lenkkeri, M. Mannikko, P. McCready, J. Lamerdin, O. Gribouval, P.M. Niaudet, and et al. Structure of the gene for congenital nephrotic syndrome of the Finnish type (NPHS1) and characterization of mutations American Journal of Human Genetics 64 1999 51 61
30. E.J. Lewis, L.G. Hunsicker, R.P. Bain, and R.D. Rohde The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group New England Journal of Medicine 329 1993 1456 1462
31. J.Y. Li, T.Y. Yong, M.Z. Michael, and J.M. Gleadle Review: The role of microRNAs in kidney disease Nephrology (Carlton, Vic.) 15 2010 599 608
32. C.L. Lin, P.H. Lee, Y.C. Hsu, C.C. Lei, J.Y. Ko, P.C. Chuang, and et al. MicroRNA-29a promotion of nephrin acetylation ameliorates hyperglycemia-induced podocyte dysfunction Journal of the American Society of Nephrology: JASN 25 2014 1698 1709
33. S. Luense, P. Denner, A. Fernandez-Montalvan, I. Hartung, M. Husemann, C. Stresemann, and et al. Quantification of histone H3 Lys27 trimethylation (H3K27me3) by high-throughput microscopy enables cellular large-scale screening for small-molecule EZH2 inhibitors Journal of Biomolecular Screening 20 2015 190 201
34. J. McCormick, N. Suleman, T.M. Scarabelli, R.A. Knight, D.S. Latchman, and A. Stephanou STAT1 deficiency in the heart protects against myocardial infarction by enhancing autophagy Journal of Cellular and Molecular Medicine 16 2012 386 393
35. F. Miao, Z. Chen, S. Genuth, A. Paterson, L. Zhang, X. Wu, and et al. Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes Diabetes 63 2014 1748 1762
36. F. Miao, X. Wu, L. Zhang, Y.C. Yuan, A.D. Riggs, and R. Natarajan Genome-wide analysis of histone lysine methylation variations caused by diabetic conditions in human monocytes The Journal of Biological Chemistry 282 2007 13854 13863
37. J.C. Milne, P.D. Lambert, S. Schenk, D.P. Carney, J.J. Smith, D.J. Gagne, and et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes Nature 450 2007 712 716
38. D.M. Nathan, P.A. Cleary, J.Y. Backlund, S.M. Genuth, J.M. Lachin, T.J. Orchard, and et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes New England Journal of Medicine 353 2005 2643 2653
39. H. Noh, E.Y. Oh, J.Y. Seo, M.R. Yu, Y.O. Kim, H. Ha, and et al. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury American Journal of Physiology. Renal Physiology 297 2009 F729 F739
40. J. Okabe, C. Orlowski, A. Balcerczyk, C. Tikellis, M.C. Thomas, M.E. Cooper, and et al. Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells Circulation Research 110 2012 1067 1076
41. A.S. Olsen, M.P. Sarras Jr., A. Leontovich, and R.V. Intine Heritable transmission of diabetic metabolic memory in zebrafish correlates with DNA hypomethylation and aberrant gene expression Diabetes 61 2012 485 491
42. A. Patel, S. MacMahon, J. Chalmers, B. Neal, L. Billot, M. Woodward, and et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes New England Journal of Medicine 358 2008 2560 2572
43. L. Pirola, A. Balcerczyk, R.W. Tothill, I. Haviv, A. Kaspi, S. Lunke, and et al. Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells Genome Research 21 2011 1601 1615
44. M. Ristola, S. Arpiainen, M.A. Saleem, H. Holthofer, and S. Lehtonen Transcription of nephrin-Neph3 gene pair is synergistically activated by WT1 and NF-kappaB and silenced by DNA methylation Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 27 2012 1737 1745
45. M. Ristola, S. Arpiainen, M.A. Saleem, P.W. Mathieson, G.I. Welsh, S. Lehtonen, and et al. Regulation of Neph3 gene in podocytes - key roles of transcription factors NF-kappaB and Sp1 BMC Molecular Biology 10 2009 83
46. M. Ristola, and S. Lehtonen Functions of the podocyte proteins nephrin and Neph3 and the transcriptional regulation of their genes Clinical Science (London) 126 2014 315 328
47. J.T. Rodgers, C. Lerin, W. Haas, S.P. Gygi, B.M. Spiegelman, and P. Puigserver Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1 Nature 434 2005 113 118
48. S. Roy, R. Sala, E. Cagliero, and M. Lorenzi Overexpression of fibronectin induced by diabetes or high glucose: Phenomenon with a memory Proceedings of the National Academy of Sciences of the United States of America 87 1990 404 408
49. V. Ruotsalainen, P. Ljungberg, J. Wartiovaara, U. Lenkkeri, M. Kestila, H. Jalanko, and et al. Nephrin is specifically located at the slit diaphragm of glomerular podocytes Proceedings of the National Academy of Sciences of the United States of America 96 1999 7962 7967
50. P. Saetrom, O. Snove Jr., and J.J. Rossi Epigenetics and microRNAs Pediatric Research 61 2007 17R 23R
51. C. Sapienza, J. Lee, J. Powell, O. Erinle, F. Yafai, J. Reichert, and et al. DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy Epigenetics: Official Journal of the DNA Methylation Society 6 2011 20 28
52. S.G. Sayyed, A.B. Gaikwad, J. Lichtnekert, O. Kulkarni, D. Eulberg, S. Klussmann, and et al. Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10 Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 25 2010 1811 1817
53. G. Sun, M.A. Reddy, H. Yuan, L. Lanting, M. Kato, and R. Natarajan Epigenetic histone methylation modulates fibrotic gene expression Journal of the American Society of Nephrology: JASN 21 2010 2069 2080
54. J. Tang, and S. Zhuang Epigenetics in acute kidney injury Current Opinion in Nephrology and Hypertension 24 2015 351 358
55. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus New England Journal of Medicine 329 1993 977 986
56. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy New England Journal of Medicine 342 2000 381 389
57. The Writing Team for the Diabetes Complications and Control Trial/Epidemiology of Diabetes Interventions and Complications Research Group Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) study JAMA 290 2003 2159 2167
58. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
59. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 854 865
60. K. Van Beneden, C. Geers, M. Pauwels, I. Mannaerts, D. Verbeelen, L.A. van Grunsven, and et al. Valproic acid attenuates proteinuria and kidney injury Journal of the American Society of Nephrology: JASN 22 2011 1863 1875
61. L.M. Villeneuve, M. Kato, M.A. Reddy, M. Wang, L. Lanting, and R. Natarajan Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1 Diabetes 59 2010 2904 2915
62. L.M. Villeneuve, and R. Natarajan The role of epigenetics in the pathology of diabetic complications American Journal of Physiology. Renal Physiology 299 2010 F14 F25
63. L.M. Villeneuve, M.A. Reddy, L.L. Lanting, M. Wang, L. Meng, and R. Natarajan Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes Proceedings of the National Academy of Sciences of the United States of America 105 2008 9047 9052
64. H. Waki, T. Yamauchi, and T. Kadowaki The epigenome and its role in diabetes Current Diabetes Reports 12 2012 673 685
65. X. Wang, J. Liu, J. Zhen, C. Zhang, Q. Wan, G. Liu, and et al. Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy Kidney International 86 2014 715 725
66. B.L. Wharram, M. Goyal, J.E. Wiggins, S.K. Sanden, S. Hussain, W.E. Filipiak, and et al. Podocyte depletion causes glomerulosclerosis: Diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene Journal of the American Society of Nephrology: JASN 16 2005 2941 2952
67. K.E. White, R.W. Bilous, S.M. Marshall, M. El Nahas, G. Remuzzi, G. Piras, and et al. Podocyte number in normotensive type 1 diabetic patients with albuminuria Diabetes 51 2002 3083 3089
68. L. Wickman, F. Afshinnia, S.Q. Wang, Y. Yang, F. Wang, M. Chowdhury, and et al. Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases Journal of the American Society of Nephrology: JASN 24 2013 2081 2095
69. G. Wolf, S. Chen, and F.N. Ziyadeh From the periphery of the glomerular capillary wall toward the center of disease: Podocyte injury comes of age in diabetic nephropathy Diabetes 54 2005 1626 1634
70. Q. Zhong, and R.A. Kowluru Epigenetic changes in mitochondrial superoxide dismutase in the retina and the development of diabetic retinopathy Diabetes 60 2011 1304 1313
71. Q. Zhong, and R.A. Kowluru Epigenetic modification of Sod2 in the development of diabetic retinopathy and in the metabolic memory: Role of histone methylation Investigative Ophthalmology & Visual Science 54 2013 244 250
72. Q. Zhong, and R.A. Kowluru Regulation of matrix metalloproteinase-9 by epigenetic modifications and the development of diabetic retinopathy Diabetes 62 2013 2559 2568